Vun-Sin Lim, Managing Editor of the Journal of Thoracic Oncology, shared a post on LinkedIn:
“Episode 3 of the JTO Insights podcast – Listen to key takeaways from the corresponding authors of 2 articles in the JTO May Issue.
Hosts: Alex Adjei and Tom John
Episode 3 guests: Bonnie Ky and David Planchard
Available on SoundCloud, Apple Podcasts and Spotify.”
David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared this post, adding:
“Thank you for the opportunity to discuss the importance of testing HER2 overexpression in our NSCLC patients and the activity of ADCs in monotherapy like T-DXd, as shown in the Phase 1b DESTINY-Lung03 study published in Journal of Thoracic Oncology. Big thanks to all co-authors of this important 2026 publication!”
1.Title: Changes in Cardiac Function in Patients Receiving Radiation Therapy for Lung Cancer
Authors: Ivy S. Han, Kyunga Ko, Jennifer Wei Zou, Amanda M. Smith, Nikhil Yegya-Raman, Amber Daniels, Carla Triolo, Congying Xia, Raymond H. Mak, Christian Guthier, Gerard Walls, Clifford Robinson, Michael Soike, Adam J. Kole, Nitin Ohri, Salma K. Jabbour, Marcelo F. Di Carli, Paco Bravo, Joshua D. Mitchell, Benedicte Lefebvre, Nicholas S. Wilcox, Kai Yi Wu, Jeffrey D. Bradley, Steven J. Feigenberg, Bonnie Ky
Read the Full Article.
2.Title: Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial
Authors: David Planchard, Hye Ryun Kim, Thatthan Suksombooncharoen, Rubi Li, Diego Cortinovis, Ji-Youn Han, Jens Samol, Yotsawaj Runglodvatana, Kang-Yun Lee, Gee-Chen Chang, Chun-Hui Lee, Dariusz Kowalski, Stephanie P. L. Saw, Yiqing Huang, Gerrina Ruiter, Myung-Ju Ahn, Tsung-Ying Yang, Cheng-Ta Yang, Aumkhae Sookprasert, Erica C. Nakajima, Jose Alfon, Robert McEwen, Yi-Ting Chang, James C. H. Yang
Read the Full Article.
Other Articles Featuring David Planchard on OncoDaily.